We recently published a list of 10 Stocks Wall Street Is Calling Bullish Amid Market Turmoil. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Wall Street is calling bullish amid market turmoil.
The S&P 500 is down 8.6% in a month while the Nasdaq has lost nearly 13%. Markets continue to scare retail investors as stock after stock struggles to deal with the aftermath of Donald Trump’s unpredictable and aggressive policies.
While it is advisable to stay out of the market till the dust settles, one also can’t deny that it is times like these that bring opportunities. We decided to come up with a list of stocks that are expected to go up even in the existing gloomy environment.
To come up with the list of 10 stocks that Wall Street is bullish on, we looked at stocks that were recently upgraded by analysts and have performed well in the last 5 days of trading.
A healthcare professional in a lab coat holding a microscope and looking at a slide under the lens.
Danaher Corporation (NYSE:DHR)
Danaher Corporation (NYSE:DHR) is a manufacturer, designer, and marketer of medical, industrial, research, and professional products and services. The company operates in the Diagnostics, Biotechnology, and Life Sciences segments. DHR experienced a 15% downturn in the previous year.
The company’s stock was upgraded last week by Stifel from Hold to Buy with a price target of $260. This upgrade was fueled by the analysts’ belief that the company’s recent cost-saving initiatives are likely to have a positive impact on revenue growth. Though the 2025 guidance was lower than expected, analysts think new cost-saving actions could boost revenue and margin growth. The stock jumped 2% on the upgrade and continued to recover past year’s losses.
Danaher (NYSE:DHR) reported FQ424 earning results recently. As per the result, the company exceeded revenue estimates by 1.2% YoY. While it missed EPS estimates by a small margin, analysts believe that the company’s 1Q2025 results may be less exposed to risks associated with academic/government demand.
Regardless of the less impressive current profit profile, the company is expected to drive significant acceleration in profits in the next 12 months, reaching an EPS of $9 in FY2026 as per estimates.
Overall, DHR ranks 7th on our list of stocks that Wall Street is calling bullish amid market turmoil. While we acknowledge the potential of DHR as a leading investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is as promising as DHR but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires
Disclosure: None. This article is originally published at Insider Monkey.
